The Los Angeles region is positioning itself as a major player in California's life sciences industry, with over 3,000 companies—including Amgen, Kite Pharma, and Takeda—operating in Los Angeles County, according to the LA County Department of Economic Opportunity (LA DEO), as reported on Mar. 12.
This development matters because the area is experiencing rapid growth and increasing recognition within the sector. A 2025 report from California Life Sciences (CLS) highlighted that Los Angeles is one of the state's fastest-growing life sciences hubs, generating nearly $58 billion in annual economic output. In 2024 alone, venture capital investment in the region reached $4.4 billion—a 119% increase—signaling growing investor confidence.
Stephanie Hsieh, CEO of BioscienceLA, described the local scene as “growing,” “thriving,” “vibrant,” and “innovative.” She said creativity is part of the region’s DNA due to its history in entertainment, aerospace, and engineering. Hsieh pointed to companies like Provivi in Santa Monica as examples of innovation at the intersection of biotech and other industries. "I think we’re really good as a region at pushing the boundaries on sort of what the definition of life sciences encompasses," Hsieh said.
Hsieh also emphasized the strength of local research institutions such as UCLA, USC, City of Hope, and Cedars-Sinai. "We just have this embarrassment of riches," she said. However, she acknowledged challenges including fragmentation across 88 cities within Los Angeles County and complex economic development structures. BioscienceLA aims to help organizations navigate these complexities by connecting them with suitable locations and resources.
Despite these hurdles, Hsieh noted several advantages for companies operating in Los Angeles: access to ports for imports and exports; experienced consultants; business services that expedite goods movement; opportunities for biomanufacturing; and a large talent pool with over 8,700 graduates annually entering life sciences fields. According to CLS data from TEConomy Partners’ analysis of U.S. Bureau of Labor Statistics’ QCEW data and Lightcast, more than 50,000 people are employed locally across various sectors including biopharma R&D and medical devices.
Looking ahead, both BioscienceLA and LA DEO are working toward establishing Los Angeles as a recognized global hub for life sciences innovation. In July, LA DEO launched a five-year strategy focused on expanding physical space for firms, encouraging growth and hiring, strengthening infrastructure and branding efforts, and promoting workforce inclusivity. LA DEO Director Kelly LoBianco said: "We are committed to partnering with industry stakeholders to keep our homegrown startups here, train our diverse workforce for quality life sciences jobs, and send a clear message to the global life sciences community that Los Angeles County is ready to lead."
